alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
§ 522.1002 Follicle stimulating hormone. ( a ) ( 1 ) *Specifications.* Each package contains 2 vials. One vial contains dry, powdered, porcine pituitary gland equivalent to 75 units (NIH-FSH-S1) of follicle stimulating hormone. The other vial contains 10 milliliters of aqueous diluent.
( 2 ) *Sponsor.* See No. 052923 in § 510.600(c) of this chapter.
( 3 ) *Conditions of use* — ( i ) *Dosage.* 12.5 units of follicle stimulating hormone twice a day for 3 days (a total of 75 units). To effect regression of the corpus luteum, prostaglandin should be given with the 5th dose.
( ii ) *Indications for use.* For induction of superovulation in cows for procedures requiring the production of multiple ova at a single estrus.
( iii ) *Limitations.* For intramuscular use in cows that are not pregnant and have a normal corpus luteum. Federal law restricts this drug to use by or on the order of a licensed veterinarian.
( b ) ( 1 ) *Specifications* — ( i ) *Single pack.* Each package contains 2 vials. One vial contains 700 international units (IU) porcine-pituitary-derived follicle stimulating hormone (FSH) equivalent to 400 milligrams NIH-FSH-P1, as a dry powder. The other vial contains 20 milliliters (mL) of bacteriostatic sodium chloride injection. When constituted, each milliliter of solution contains 35 IU FSH.
( ii ) *Dual pack.* Each package contains 2 vials. Each vial contains 700 international units (IU) porcine-pituitary-derived FSH equivalent to 400 milligrams NIH-FSH-P1, as a dry powder. Constitute with 20 mL bacteriostatic sodium chloride injection, using strict aseptic technique. When constituted, each milliliter of solution contains 35 IU FSH.
( 2 ) *Sponsor.* See No. 017030 in § 510.600(c) of this chapter.
( 3 ) *Conditions of use* — ( i ) *Dosage.* Administer 2.5 mL (87.5 IU) intramuscularly, twice daily at 12-hour intervals, for 4 consecutive days. In conjunction with the 6th dose, administer an approved prostaglandin product for cattle (cloprostenol sodium or dinoprost tromethamine), using the labeled dosage and administration instructions to cause luteolysis and induce estrus. See § 522.460 for use of cloprostenol sodium or § 522.690 for use of dinoprost tromethamine.
( ii ) *Indications for use.* For the induction of superovulation in beef and dairy heifers and cows.
( iii ) *Limitations.* Federal law restricts this drug to use by or on the order of a licensed veterinarian.
[58 FR 47377, Sept. 9, 1993, as amended at 62 FR 62242, Nov. 21, 1997; 76 FR 2808, Jan. 18, 2011; 79 FR 53136, Sept. 8, 2014; 79 FR 74020, Dec. 15, 2014; 82 FR 21690, May 10, 2017; 82 FR 43484, Sept. 18, 2017]
###### Editorial Note on Part 570

#### Editorial Note:

Nomenclature changes to part appear at 88 FR 45066, July 14, 2023.

#### § 570.14 Indirect food additives resulting from packaging materials for animal feed and pet food.

Regulations providing for the use of food packaging materials in parts 174 through 179 of this chapter are incorporated in Subchapter E as applicable to packaging materials used for animal feed and pet food.

[42 FR 14091, Mar. 15, 1977]
§ 556.375 Maduramicin. ( a ) [Reserved]
( b ) *Tolerances.* The tolerance for maduramicin (marker residue) is: ( 1 ) *Chickens.* Fat (target tissue): 0.38 ppm.
( 2 ) [Reserved]
( c ) *Related conditions of use.* See § 558.340 of this chapter.
Reader’s Guide for Prallethrin

CRM: Wilhelmena Livingston

EPA/OCSPP/OPP/PRD

Reader’s Guide to Prallethrin Docket # EPA-HQ-OPP-2011-1009

Publication Date: June 20, 2012

EPA has created this document to provide an organizational structure to the

Registration Review Prallethrin Docket for Public Comments. The docket index groups 

related documents. The first group contains the Federal Register and Docket 

Organizational Documents, the second group contains the Environmental Risk 

Assessment document, the third group contains the Human Health Assessment, and the 

fourth group contains use/usage information and a review of human incidents. The 

Agency is providing the “Reader’s Guide” to allow the reader to more easily access and 

navigate the various items contained in the Prallethrin docket. 

Federal Register and Docket Organizational Documents:

Docket Item 1. Federal Register Notice: Prallethrin Registration Review

Docket Item 2. Reader’s Guide to the Prallethrin Docket # EPA-HQ-

 OPP-2011-1009

Docket Item 3. Prallethrin Preliminary Work Plan Document

June 8, 2012)

Environmental Fate and Effects Documents for Registration Review

Docket Item 4. Registration Review - Problem Formulation for Environmental 

Fate, Ecological Risk, Endangered Species, and Drinking Water 

Assessments for Prallethrin 

(April 17, 2012)

This document provides an overview of what is currently known about the environmental 

fate and ecological effects associated with prallethrin and its degradates, and outlines

uncertainties regarding attributes of the parent compound and its transformation 

products.

Human Health Document for Registration Review

Docket Item 5. Prallethrin: Human Heath Assessment Scoping Document in 

Support of Registration Review

(May 10, 2012)
This document evaluates the status of the human health assessments to determine the 

scope of work necessary to support the registration review of the selective herbicide 

Prallethrin.

Human Incidents

Docket Item 6. Prallethrin: Review of Human Incidents

(February 14, 2012)

This report represents poisoning incidents occurring in the United States for Prallethrin.

Use and Usage Information for Registration Review

Docket Item 7. BEAD Chemical Profile for Registration Review: Prallethrin 

(128722)

(December 28, 2011)

The purpose of this document is to convey usage information and a broad overview of the 

pest management roles of pesticides that are beginning to undergo registration review.

Docket Item 8. Prallethrin (128722) Cal. DPR Usage Data

(January 17, 2012)

This document provides publicly available data from the California Department of 

Pesticide Regulation (CADPR) that outlines the pounds of Prallethrin used in California 

over the three most recent years (2008 – 2010).

Docket Item 9. PRD Label Data Report: Food/Feed & Non-Food/Non Feed Uses 

Considered in Registration Review Work Planning

Prallethrin (128722)

(September 21, 2011)

This table lists the food/feed and non-food/non- feed uses for Prallethrin.
SHERIDAN HEALTHCARE, INC.
                                  EXHIBIT 21.1
                    Schedule of Subsidiaries and Affiliates
                           (As of December 31, 1996)

I.   SUBSIDIARIES:

     A. SHERIDAN HEALTHCORP, INC., a Florida corporation

        SUBSIDIARIES:

         1.   SHERIDAN HEALTHCARE OF WEST FLORIDA,  INC., a Florida corporation
              f/k/a AMSA, Inc.

         2.   PRIMEDICA HEALTHCARE, INC., a Florida corporation

         3.   AARDS,  INC., a Florida  corporation  f/k/a Norman Gaylis,  M.D.,
              P.A.

         4.   ROSENBAUM,  WEITZ AND RITTER,  INC., a Florida  corporation f/k/a
              Rosenbaum, Weitz & Ritter, M.D., P.A.

     B. MEDISERV,INC.,a Florida corporation f/k/a Group Practice Management,Inc.

     C.  SHERIDAN CHILDREN'S HEALTHCARE SERVICES, INC.,
         a Florida corporation f/k/a Neonatology Certified, Inc.

         SUBSIDIARY:

          1.   SHERIDAN CHILDREN'S HEALTHCARE SERVICES OF WEST VIRGINIA, INC., a
               West Virginia corporation

     D.  CHILDREN'S HOSPITAL SERVICES, INC., a Florida corporation

     E.  SHERIDAN HEALTHCARE OB/GYN, INC.,
         a Florida corporation f/k/a Sheridan Healthcare of Puerto Rico, Inc.

     F.  SHERIDAN FINANCE CORP., a Delaware corporation

II   AFFILIATES:

     A.  SHERIDAN MEDICAL HEALTHCORP, P.C., a New York professional corporation

         SUBSIDIARY:

          1.   SHERIDAN STC CORP., a Delaware corporation

     B.  SHERIDAN HEALTHCARE OF TEXAS, P.A., a Texas professional association

     C.  SHERIDAN HEALTHCARE OF CALIFORNIA MEDICAL GROUP, INC.,
         a California professional corporation

     D.  ARTHRITIS AND RHEUMATIC DISEASE SPECIALTIES, P.A.,
         a Florida professional association
<TABLE> <S> <C>

<PAGE>
 
<ARTICLE> 9
       
<S>                             <C>
<PERIOD-TYPE>                   YEAR
<FISCAL-YEAR-END>                          JUN-30-1997
<PERIOD-END>                               JUN-30-1997
<CASH>                                           1,075
<INT-BEARING-DEPOSITS>                           4,732
<FED-FUNDS-SOLD>                                     0
<TRADING-ASSETS>                                     0
<INVESTMENTS-HELD-FOR-SALE>                     17,621
<INVESTMENTS-CARRYING>                          44,157
<INVESTMENTS-MARKET>                            44,250
<LOANS>                                         36,256
<ALLOWANCE>                                         76
<TOTAL-ASSETS>                                 105,434
<DEPOSITS>                                      86,759
<SHORT-TERM>                                         0
<LIABILITIES-OTHER>                                743
<LONG-TERM>                                          0
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                            15
<OTHER-SE>                                      17,916
<TOTAL-LIABILITIES-AND-EQUITY>                 105,434
<INTEREST-LOAN>                                  2,734
<INTEREST-INVEST>                                4,491
<INTEREST-OTHER>                                   288
<INTEREST-TOTAL>                                 7,513
<INTEREST-DEPOSIT>                               4,534
<INTEREST-EXPENSE>                               4,534
<INTEREST-INCOME-NET>                            2,979
<LOAN-LOSSES>                                        0
<SECURITIES-GAINS>                                   0
<EXPENSE-OTHER>                                  2,842
<INCOME-PRETAX>                                    222
<INCOME-PRE-EXTRAORDINARY>                         222
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                       143
<EPS-PRIMARY>                                     0.12
<EPS-DILUTED>                                     0.12
<YIELD-ACTUAL>                                    7.32
<LOANS-NON>                                          0
<LOANS-PAST>                                         0
<LOANS-TROUBLED>                                     0
<LOANS-PROBLEM>                                      0
<ALLOWANCE-OPEN>                                    78
<CHARGE-OFFS>                                        2
<RECOVERIES>                                         0
<ALLOWANCE-CLOSE>                                   76
<ALLOWANCE-DOMESTIC>                                 0
<ALLOWANCE-FOREIGN>                                  0
<ALLOWANCE-UNALLOCATED>                             76
        

</TABLE>
563 P.2d 908

#### The STATE of Arizona, Appellee, v. Charles MICHELENA, Appellant.

No. 2 CA-CR 917.

Court of Appeals of Arizona, Division 2.

Jan. 28, 1977.

Rehearing Denied March 30, 1977.

Review Denied May 3, 1977.

Bruce E. Babbitt, Atty. Gen., by Heather Sigworth, Asst. Atty. Gen., Tucson, for appellee.

Robert L. Murray, Tucson, for appellant.

OPINION

RICHMOND, Judge.

Appellant was found guilty of unlawful possession of a narcotic drug in violation of A.R.S. § 36-1002, as amended. The court imposed a sentence of a fine of $600, to be paid $50 per month, and ordered that appellant be incarcerated in the Pima County Jail until the fine was paid but that the execution of the jail sentence be suspended for one year and that appellant be placed on probation for that period.

Appellant’s basis of appeal is the trial court’s denial of his motion to suppress. The facts applicable to the disposition of this case are as follows. Deputy Sheriff Fiscella testified that he stopped appellant for a speeding violation and, when he did so, determined that there was an outstanding warrant for appellant’s arrest. He informed appellant that he was under arrest and searched him for weapons and contraband but failed to find either. Appellant was advised that if he had anything on his person that had been missed in the search, he should tell the officer then because a strip search would be conducted at the jail and it would be found anyway. The officer did not advise appellant of his *Miranda*rights. Appellant then informed the officer that he had drugs in his pocket, and the officer removed a usable amount of cocaine from appellant’s shirt pocket.

Whether the exclusionary rule applies in a *no-Miranda*warning situation is not necessary to the disposition of this case. Assuming arguendo that it does, there is a recognized exception as to evidence derived from an unlawful search or other illegal police conduct where the normal course of police investigation would, in any event, even absent the illicit conduct, have inevitably led to such evidence. *People v. Fitzpatrick,*32 N.Y.2d 499, 346 N.Y.S.2d 793, 300 N.E.2d 139 (1973), and authorities cited therein.

The detention officer at the Pima County main detention facility testified at the suppression hearing that whenever someone is booked into the detention facility, a strip search is performed and the clothing is gone through inside and out for contraband. Under such a search the cocaine would have been found in appellant’s *110shirt pocket. The motion to suppress therefore was properly denied.

We have reviewed the entire record, A.R.S. § 13-1715, and find no fundamental error. The judgment and sentence are affirmed.

HOWARD, C. J., and HATHAWAY, J., concurring.
#### State of Connecticut *v.*Grady Cobb

*Grady Cobb,*pro se, on the motion.

Submitted November 12

decided November 25, 1969

The motion by the defendant for a writ of mandamus and an interim disclosure of the progress of his appeal from the Superior Court in Fairfield County is dismissed.
EXHIBIT 5.1

                                  July 6, 2000

Board of Directors
Elcotel, Inc.
6428 Parkland Drive

Sarasota, Florida 34243

      Re: Registration Statement on Form S-8
          ----------------------------------

Gentlemen:

      We have acted as counsel for Elcotel, Inc. ("Elcotel") in connection with
the preparation and filing with the Securities and Exchange Commission under the
Securities Act of 1933 of a Registration Statement on Form S-8 relating to
shares of common stock of Elcotel (the "Shares") covered by the options granted
to optionees under the Elcotel, Inc. 1999 Stock Option Plan (the "Options").

      As counsel for Elcotel, we have examined such corporate records and other
documents of Elcotel and considered such questions of law as we have deemed
necessary or appropriate for purposes of this opinion. On the basis of such
examination, we are of the opinion that the Shares have been duly authorized,
and when duly issued against payment of the purchase price therefor pursuant to
the Options and due exercise of the options thereunder, will be validly issued,
fully paid and non-assessable.

      We hereby consent to the inclusion of this opinion as Exhibit 5.1 to the
Registration Statement.

                                            Very truly yours,

                                            SCHNADER HARRISON SEGAL & LEWIS LLP
§ 524.998 Fluralaner. ( a ) *Specifications.* Each milliliter of solution contains 280 milligrams (mg) fluralaner.
( b ) *Sponsor.* See No. 000061 in § 510.600(c) of this chapter.
( c ) *Conditions of use* — ( 1 ) *Dogs* — ( i ) *Amount.* Administer topically as a single dose every 12 weeks according to the label dosage schedule to provide a minimum dose of 11.4 mg/lb (25 mg/kg) body weight. May be administered every 8 weeks in case of potential exposure to *Amblyomma americanum* ticks.
( ii ) *Indications for use.* Kills adult fleas; for the treatment and prevention of flea infestations (*Ctenocephalides felis*) and the treatment and control of tick infestations (*Ixodes scapularis* (black-legged tick), *Dermacentor variabilis* (American dog tick), and *Rhipicephalus sanguineus* (brown dog tick)) for 12 weeks in dogs and puppies 6 months of age and older, and weighing 4.4 lb or greater; for the treatment and control of *A. americanum* (lone star tick) infestations for 8 weeks in dogs and puppies 6 months of age and older, and weighing 4.4 lb or greater.
( iii ) *Limitations.* Federal law restricts this drug to use by or on the order of a licensed veterinarian.
( 2 ) *Cats* — ( i ) *Amount.* Administer topically as a single dose every 12 weeks according to the label dosage schedule to provide a minimum dose of 18.2 mg/lb (40 mg/kg) body weight. May be administered every 8 weeks in case of potential exposure to *D. variabilis* ticks.
( ii ) *Indications for use.* Kills adult fleas; for the treatment and prevention of flea infestations (*C. felis*) and the treatment and control of *I. scapularis* (black-legged tick) and *Haemaphysalis longicornis* (Asian longhorned tick) infestations for 12 weeks in cats and kittens 6 months of age and older, and weighing 2.6 lb or greater; for the treatment and control of *D. variabilis* (American dog tick) infestations for 8 weeks in cats and kittens 6 months of age and older, and weighing 2.6 lb or greater.
( iii ) *Limitations.* Federal law restricts this drug to use by or on the order of a licensed veterinarian.
[81 FR 67152, Sept. 30, 2016, as amended at 82 FR 43485, Sept. 18, 2017; 88 FR 14901, Mar. 10, 2023]
Argued and submitted November 19,

affirmed December 29, 1999

#### STATE OF OREGON, *Respondent, v.*DANIEL JAMES SIMPSON, *Appellant.*

(973118C; CA A101445)

993 P2d 190

Kimi Nam, Deputy Public Defender, waived oral argument for appellant. With her on the brief was David E. Groom, Public Defender.

Timothy A. Sylwester, Assistant Attorney General, argued the cause for respondent. With him on the brief were Hardy Myers, Attorney General, and Michael D. Reynolds, Solicitor General.

Before De Muniz, Presiding Judge, and Haselton and Wollheim, Judges.

PER CURIAM

Affirmed. *State v. Thayer,*158 Or App 440, 974 P2d 699 (1999).
- All
            - Title
            - Author
            - Subject
            - Date
            - Full-Text

            -                              Explore                            ******                - Educational Resources
              - Archival Collections
              -                                      Themes                                    ******                  - Economic Data
                - Federal Reserve
                - View all 
              - Timelines 
            -                              Browse                            ******                - Titles
              - Authors
              - Subjects
              - Dates 
            -                              About                            ******                - About FRASER
              - FAQ
              - Contact Us
              -                                      FRASER API                                    ******                  - REST API
                - OAI-PMH 
            - Inside FRASER Blog

            - **

Home                 > Browse by Title > Materials Prepared in Connection with the Study of Employment, Growth, and Price Levels for Consideration by the Joint Economic Committee, Congress of the United States

              																								United States. Congress. Joint Economic Committee, 1956-					 and 	Eighty-Sixth Congress, 1959-1961.						"Study Paper No. 18 : National Security and the American Economy in the 1960s" in *Materials Prepared in Connection with the Study of Employment, Growth, and Price Levels for Consideration by the Joint Economic Committee, Congress of the United States*			(January 30, 1960).						https://fraser.stlouisfed.org/title/1244/item/3647, accessed on September 26, 2024.	    

        - **FRASER**
        - About
        - FAQ
        - Legal and Privacy
        - FRASER API

          -                              @FedFRASER 
          - ** Contact Us
          -  **  What's New  
          -  **  Inside FRASER
# Materials Not Included in **Airworthiness Directive (AD) Docket**

Docket Number: F AA - 2014 - 0750 Directorate Identifier: 2014NM147AD

601R - 71 - 034, Rev A --- 4/28/14 601R - 71 - 034 --- 3/31/14

Name/Description of Item(s) Not Included in FDMS Docket and Maintained in the Supplemental AD Docket 

### MA **Y BE VIEWED AT:** Federal Aviation Administration

Transport Airplane Directorate Rules Docket 1601 Lind Ave. SW., Renton, WA 98057 425.227.1221 **DURING THE HOURS OF:** 9 a.m. and 3 p.m., Monday through Friday, except Federal holidays. Form Date: 0 3/05/2008
Reserve RD

Quemado RD

Quemado RD

Glenwood RD

Quemado R

D

Spr ni gerville R

D

æäAP

4225

¬«435

¬«12

Green el e County

Catron County Catron County

Apache County

Þ¿49

Þ¿4000M

Þ¿545

Þ¿306

Þ¿35

Þ¿209

36Þ¿

2Þ¿20

çå141

çå385

æäB

012

æäB

080

æäB

024

æäB

007

æäB

002

æäB

003

æäB

026

æäB

025

æäB

083

æäB

013

æäB

009

æäB

089

æäB

029

Lower San

Francisco

Plaza

Luna

Reserve

San

Francisco

Plaza

(/180

(/180

Arizona

New

Mex ci o

White

Bluff

7241

Maverick

Peak

7881

Dillon

Mountain

8694

Turner

Peak

9429

Maness

Mountain

8094

Mess Box

Mesa

7743

Black Bull

Peak

8369

Black

Peak

9006

San Francisco

Mountains

8465

Jones

Peak

9022

Hell Roaring

Mesa

8514

Freeman

Mountain

8773

Maness

Peak

8258

Higgins

Mountain

6486

Bishop

Peak

8855

Prairie

Point Peak

8333

Negrohead

Butte

7887

Maness

Mountain

7995

Monument

Mountain

8333

Horse

Mesa

8438

Jim Smith

Peak

9252

Joe Green

Peak

7897

Bill Lewis

Mesa

7260

Hellroaring

Mesa

7858

Bill Lee

Mesa

8219

Bar N L

Mesa

8136

Red Butte

8123

Turner

Peak

9170

Leggett

Peak

7930

Bar NL

Mesa

7644

§¦180

2

æäAP

2310

æäGR

67004

124

63

1261

769

62

351

33

762

36

9

515

125

21

34

35

119

761

126

109

64

956

61

çå275

Centerfire

Cr.

Coyote

Cr.

San

Francisco R.

TularosaR.

San

Francisco R.

StoneCr.

San Francisco R.

Dry BlueCr.

Blue

R.

San

Francisco R.

San

Francisco R.

Dillman Cr.

Dry

Blue

Cr.

Pace Cr.

Stone

Cr.

Tularosa R.

Coyote Cr. Coyote

Cr.

Coyote

Cr.

Coyote Cr.

Trou

Cr

t

.

Luna Planning Area

Luna (185,586 ac.)

! City/Town

Stream

Highway

Improved Road, Paved

Improved Road, Gravel

Improved Road, Dirt

Unimproved Road

Non-motorized Trail

Motorized Trail

H Transmission Line

National Forest Boundary

Ranger District Boundary

County Boundary

US Forest Service

FS Wilderness

Bureau of Land Mgmt.

Private

State

Vegetation Treatment Areas

Grassland Treatment

Rabbit Brush Treatment

LUNA RESTORATION PROJECT: FIGURE 4

0 1 2 4

Miles

Created On: 5/11/2016 1:36:17 PM

Coordinate System: NAD 1983 UTM Zone 12NTransverse Mercator

o 1 in = 2 miles

1:125,000

(printed on 11" x 17" portrait layout)

Created By: jjelacic

The USDA is an equal opportunity provider, employer, and lender

Figure 4: Location of grassland

and rabbit brush areas

proposed for maintenance and

restoration treatments.